Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

S&P 500 Grind Higher Goes On, Regardless of Daily Setbacks

The runup to yesterday’s US open and the regular session’s trading confirmed my call that stocks would break above the key resistances. And they did effortlessly overcome the upper border of March’s gap and the 61.8% Fibonacci re...

CureVac, BioNTech, Valeo Pharma: Where is there still potential?

The race for vaccines against Covid-19 is fierce. Every day there are new water level reports - from setbacks to breakthroughs, everything is there. The Tübingen-based Company CureVac ( NASDAQ: CVAC ) recently started its phase study IIa in Peru and Panama. Around 700 people...

Health Insurance Sector Indicates Growth in the Near Future

As continuous reforms hit the healthcare industry in the United States, millions have pushed forward the demands for comprehensive and convenient medical coverage in the form of lth insurance business has faced some setbacks due to various changes in regulations limiting their...

Bull in the China stocks?

The global economic expansion continues apace, albeit not without hiccups and setbacks focused around the PIIGS group of nations. There, we recently saw trouble manifest in Fitch Ratings Agency’s downgrade of Portuguese sovereign debt (from AA to AA-), an eve...

Buzz on the Bullboards: Buying Binge or Sell-Off Frenzy?

Adrift in a sea of global economic uncertainty and confusion, last week was full of tough questions for investors on the Stockhouse Bullboards. Some of the most popular companies on the website suffered setbacks, while other small caps gained attention as investors looked...

Buzz on the Bullboards: The Best of 2019

It was a year of ups, downs, and everything in between. It was also a year marked by global economic uncertainty and a shakeup of some of the hottest investment sectors. Yet as 2019 winds down, a clear picture emerges. Markets recovered and hit new records after falling st...

New Day, New Test of the Great S&P 500 Bull Run

Egged on by the horrendous retail sales data, S&P 500 intraday decline has gathered steam yesterday. An 8.7% drop in consumer spending can’t be just waved off. Neither can the Empire State Manufacturing Index at -78.2. We have the impression that the world is w...

Barrick Gold, Blackrock Gold, Osino Resources: buy when weak?

The price of gold and silver has come under pressure in the past few days and so too has the price of the shares of the companies involved in the creation of value for precious metals. The fear of another lockdown in connection with the Corona Pandemic seems to be worrying the...

Buzz on the Bullboards: Who’s filling the void in the tech selloff?

Last week was full of tough questions for investors navigating the waters of a sea of global economic uncertainty and confusion. Investors remain in a holding pattern as we witnessed some of the most popular companies among our communities (many in the tech sector) st...

BioNTech & Cardiol Therapeutics – on the verge of a breakout

Compared with the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition t...
1 2 3 4 5 6 7 8 9 10 ...